Skip to main content

DarioHealth Corp

For the period ended Jun 30, 2024. Filed Aug 8, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 8, 2024

DRIO$2.06-13.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Interim Statements of Stockholders’ Equity

​​​​​​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Additional · ​ · ​ · ​ · ​ · Total
​ · ​ · Common Stock · ​ · Preferred Stock · ​ · paid-in · ​ · Accumulated · ​ · stockholders’
Three Months Ended June 30, 2024 · ​ · Number · ​ · Amount · ​ · Number · ​ · Amount · ​ · capital · ​ · deficit · ​ · equity
Balance as of March 31, 2024 (unaudited)29,439,740​$341,381​$*)-​$436,600​$(358,570)​$78,033
​​​​​​​​​​​​​​​​​​​​
Exercise of options4,688​*)-—​—​*)-​—​*)-
Extinguishment of preferred stock in connection with preferred stock modification—​——​—​(11,786)​11,786​—
Deemed dividend related to issuance of preferred stock—​——​—​3,080​(3,080)​—
Issuance of warrants to service providers—​——​—​2,001​—​2,001
Conversion of preferred stock to common stock376,810​*)-(1,050)​*)-​—​—​—
Stock-based compensation203,037​*)-—​—​1,561​—​1,561
Modification of warrants—​​*)-​—​​—​​70​​—​​70
Net loss—​——​—​—​(13,610)​(13,610)
​​​​​​​​​​​​​​​​​​​​
Balance as of June 30, 2024 (unaudited)30,024,275​$340,331​$*)-​$431,526​$(363,474)​$68,055
​​​​​​​​​​​​​​​​​​​​
​​​​​​​​​​​​Additional​​​​Total
​​Common Stock​Preferred Stock​paid-in​Accumulated​stockholders’
Six Months Ended June 30, 2024​Number​Amount​Number​Amount​capital​deficit​equity
Balance as of December 31, 2023 (audited)27,191,849$318,959$*)-$407,502$(349,361)$58,144
​​​​​​​​​​​​​​​​​​​​
Exercise of options6,709​*)-—​—​*)-​—​*)-
Extinguishment of preferred stock in connection with preferred stock modification—​——​—​(11,786)​​11,786​—
Deemed dividend related to issuance of preferred stock—​——​—​5,114​​(5,114)​—
Issuance of warrants to service providers—​——​—​2,028​—​2,028
Stock-based compensation2,048,907​*)-—​—​8,392​—​8,392
Conversion of preferred stock to common stock776,810​*)-(1,050)​*)-​—​—​—
Issuance of preferred stock, net of issuance cost—​​—​22,422​​*)-​​20,206​​​​20,206
Modification of warrants​—​*)-—​—​70​—​70
Net Profit—​——​—​—​(20,785)​(20,785)
​​​​​​​​​​​​​​​​​​​​
Balance as of June 30, 2024 (unaudited)30,024,275​$340,331​$*)-​$431,526​$(363,474)​$68,055
​​​​​​​​​​​​​​​​​​​​

*) Represents an amount lower than $1.

INTERIM STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) (Cont.)

​​​​​​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Additional · ​ · ​ · ​ · ​ · Total
​ · ​ · Common Stock · ​ · Preferred Stock · ​ · paid-in · ​ · Accumulated · ​ · stockholders’
Three Months Ended June 30, 2023 · ​ · Number · ​ · Amount · ​ · Number · ​ · Amount · ​ · capital · ​ · deficit · ​ · equity
Balance as of March 31, 2023 (unaudited)25,875,295​$3​3,557​$*)-​$370,702​$(298,675)$72,030
​​​​​​​​​​​​​​​​​​​​
Exercise of options​4,800​​*)-​—​​—​​*)-​​—​​*)-
Extinguishment of preferred stock in connection with preferred stock modification—​-—​—​984​(984)​—
Deemed dividend related to issuance of preferred stock​—​​—​—​​—​​707​​(707)​​—
Issuance of warrants to service providers​—​​—​—​​—​​595​​—​​595
Issuance of warrants related to loan agreement, net of issuance cost​—​​—​—​​—​​1,389​​—​​1,389
Stock-based compensation​472,199​​*)-​—​​—​​4,697​​—​​4,697
Issuance of common stock and preferred stock, net of issuance cost​355,743​​*)-​15,402​​*)-​​16,278​​—​​16,278
Release of common stock related to earnout consideration​76,637​​*)-​—​​-​​—​​—​​—
Net loss​—​​—​—​​—​​—​​(16,585)​​(16,585)
​​​​​​​​​​​​​​​​​​​​
Balance as of June 30, 2023 (unaudited)26,784,674​$318,959​$*)-​$395,352​$(316,951)​$78,404
​​​​​​​​​​​​​​​​​​​​
​​​​​​​​​​​​Additional​​​​Total
​​Common Stock​Preferred Stock​paid-in​Accumulated​stockholders’
Six Months Ended June 30, 2023​Number​Amount​Number​Amount​capital​deficit​equity
Balance as of December 31, 2022 (audited)25,724,470$33,567$*)-$365,846$(285,850)$79,999
​​​​​​​​​​​​​​​​​​​​
Exercise of options4,800​*)-—​—​*)-​—​*)-
Extinguishment of preferred stock in connection with preferred stock modification—​——​—​984​(984)​—
Deemed dividend related to issuance of preferred stock—​——​—​707​(707)​—
Issuance of warrants to service providers​—​——​—​1,225​—​1,225
Issuance of warrants related to loan agreement, net of issuance cost​—​——​​—​​1,389​​—​1,389
Stock-based compensation​619,442​*)-—​—​8,923​—​8,923
Conversion of preferred stock to common stock3,582​*)-(10)​—​—​—​—
Issuance of common stock and preferred stock, net of issuance cost355,743​​*)-​15,402​​*)-​​16,278​​—​16,278
Repurchase and retirement of common stock​76,637​​*)-​—​​—​​—​​—​​*)-
Net loss—​——​—​—​(29,410)​(29,410)
​​​​​​​​​​​​​​​​​​​​
Balance as of June 30, 2023 (unaudited)26,784,674​$318,959​$*)-​$395,352​$(316,951)​$78,404
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.